RT Journal Article
SR Electronic
T1 Update on Research and Future Directions of the OMERACT MRI Inflammatory Arthritis Group
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP 2031
OP 2033
DO 10.3899/jrheum.110419
VO 38
IS 9
A1 PHILIP G. CONAGHAN
A1 FIONA M. McQUEEN
A1 PAUL BIRD
A1 CHARLES G. PETERFY
A1 ESPEN A. HAAVARDSHOLM
A1 FRÉDÉRIQUE GANDJBAKHCH
A1 PERNILLE BØYESEN
A1 LAURA COATES
A1 BO EJBJERG
A1 IRIS ESHED
A1 VIOLAINE FOLTZ
A1 KAY-GEERT HERMANN
A1 JANE FREESTON
A1 SIRI LILLEGRAVEN
A1 MARISSA LASSERE
A1 CHARLOTTE WIELL
A1 ALLEN ANANDARAJAH
A1 ANNE DUER-JENSEN
A1 PHILIP O’CONNOR
A1 HARRY K. GENANT
A1 PAUL EMERY
A1 MIKKEL ØSTERGAARD
YR 2011
UL http://www.jrheum.org/content/38/9/2031.abstract
AB The OMERACT Magnetic Resonance Imaging (MRI) Task Force has developed and evolved the psoriatic arthritis MRI score (PsAMRIS) over the last few years, and at OMERACT 10, presented longitudinal evaluation by multiple readers, using PsA datasets obtained from extremity MRI magnets. Further evaluation of this score will require more PsA imaging datasets. As well, due to improved image resolution since the development of the original rheumatoid arthritis MRI scoring system (RAMRIS), the Task Force has worked on semiquantitative assessment of joint space narrowing, and developed a reliable method as a potential RAMRIS addendum, although responsiveness will need to be evaluated. One of the strengths of MRI is the ability to detect subclinical synovitis, so the group worked on obtaining low disease activity/clinical remission datasets from a number of international centers and presented cross-sectional findings. Subsequent longitudinal evaluation of this unique resource will be a major continuing focus for the group.